Association of Angiotensin-Converting Enzyme Insertion(I)/Deletion (D) Genotype in Alzheimer's Disease Patients of North Indian Population

REFERENCES

• Amouyel, P., Richard, F., Cottel, D., Amant, C., Codron, V., & Helbecque, N. (1996). The deletion allele of the angiotensin I converting enzyme gene as a genetic susceptibility factor for cognitive impairment. Neuroscience Letters, 217, 203–205.
   PubMed Web of Science ®Google Scholar
• Arregui, A., Perry, E. K., Rossor, M., & Tomlinson, B. E. (1982). Angiotensin converting enzyme in Alzheimer's disease increased activity in caudate nucleus and cortical areas. Journal of Neurochemistry, 38, 1490–1492.
   PubMed Web of Science ®Google Scholar
• Barnes, N. M., Cheng, C. H., Costall, B., Naylor, R. J., Williams, T. J., & Wischik, C. M. (1991). Angiotensin converting enzyme density is increased in temporal cortex from patients with Alzheimer's disease. European Journal of Pharmacology, 200, 289–292.
   PubMed Web of Science ®Google Scholar
• Buss, S., Muller-Thomsen, T., Hoch, C., Alberici, A., Binetti, G., & Nitsch, R. M. (2002). No association between DCP1 genotype and late-onset Alzheimer's disease. American Journal of Medical Genetics, 114, 440–445.
   PubMed Web of Science ®Google Scholar
• Farrer, L. A., Sherbatich, T., Keryanov, S. A., Korovaitseva, G. I., Rogaeva, E. A., & Petruk, S. (2000). Association between angiotensin-converting enzyme and Alzheimer's disease. Archives of Neurology, 57, 210–214.
   PubMedGoogle Scholar
• Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) Mini-mental state: A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatry Research, 12, 189–198.
   PubMed Web of Science ®Google Scholar
• Furuya, K., Yamaguchi, E., Hirabayashi, T., Itoh, A., Hizawa, N., & Ohnuma, N. (1994). Angiotensin-I-converting enzyme gene polymorphism and susceptibility to cough. Lancet, 343, 354.
   PubMed Web of Science ®Google Scholar
• Harrap, S. B., Tzourio, C., Cambien, F., Poirier, O., Raoux, S., Chalmers, J. (2003). The ACE gene I/D polymorphism is not associated with the blood pressure and cardiovascular benefits of ACE inhibition. Hypertension, 42, 297–310.
   PubMed Web of Science ®Google Scholar
• Hemming, M. L., & Selkoe, D. J. (2005) Amyloid beta-protein is degraded by cellular angiotensin-converting enzyme (ACE) and elevated by an ACE inhibitor. Journal of Biological Chemistry, 280, 37644–37650.
   PubMed Web of Science ®Google Scholar
• Hu, J., Igarashi, A., Kamata, M., & Nakagawa, H. (2001). Angiotensinconverting enzyme degrades Alzheimer amyloid beta-peptide (A-beta) retards A beta aggregation, deposition, fibril formation; and inhibits cytotoxicity. Journal of Biological Chemistry, 276, 47863–47868.
   PubMed Web of Science ®Google Scholar
• Kehoe, P. G., Russ, C., McIlory, S., Williams, H., Holmans, P., Holmes, C., (1999). Variation in DCP1, encoding ACE, is associated with susceptibility to Alzheimer's disease, Nature Genetics, 21, 71–72. [PubMed: 9916793].
   PubMed Web of Science ®Google Scholar
• Lendon, C. L., Thaker, U., Harris, J. M., McDonagh, A. M., Lambert, J. C., & Chartier-Harlin, M. C. (2002). The angiotensin 1—converting enzyme insertion(I)/deletion(D) polymorphism does not influence the extent of amyloid or tau pathology in patients with sporadic Alzheimer's disease. Neuroscience Letters, 328, 314–318.
   PubMed Web of Science ®Google Scholar
• Miners, J. S., Ashby, E., Van Helmond, Z., Chalmers, K. A., Palmer, L. E., Love, S. (2008). Angiotensin-converting enzyme (ACE) levels and activity in Alzheimer's disease, and relationship of perivascular ACE-1 to cerebral amyloid angiopathy. Neuropathology and Applied Neurobiology, 34, 181–193.
   PubMed Web of Science ®Google Scholar
• Monastero, R., Caldarella, R., Mannino, M., Cefalu, A. B., Lopez, G., & Noto, D. (2002). Lack of association between angiotensin converting enzyme polymorphism and sporadic Alzheimer's disease. Neuroscience Letters, 335, 147–149.
   PubMed Web of Science ®Google Scholar
• Myllykangas, L., Polvikoski, T., Sulkava, R., Cefalu, A. B., Lopez, G., & Noto, D. (2000). Cardiovascular risk factors and Alzheimer's disease: A genetic association study in a population aged 85 or over. Neuroscience Letters, 292, 195–198.
   PubMed Web of Science ®Google Scholar
• Oba, R., Igarashi, A., Kamata, M., Nagata, K., Takano, S., & Nakagawa, H. (2005). The N-terminal active centre of human angiotensin converting enzyme degrades Alzheimer amyloid beta-peptide. European Journal of Neuroscience, 21, 733–740.
   PubMed Web of Science ®Google Scholar
• Oruc, N., Lamb, J., Kutlu, O. C., Barmada, M. M., Money, M. E., Silvka, A. (2004). The functional Angiotensin converting enzyme Gene I/D Polymorphism does not alter Susceptibility to chronic pancreatitis. Jouranal of Pancreas, 5(6), 457–463.
   PubMedGoogle Scholar
• Palumbo, B., Cardini, D., Nocentini, G., Filipponi, E., Fravolini, M. L., & Senin, U. (1999). Angiotensin converting enzyme deletion allele in different kinds of dementia disorders. Neuroscience Letters, 267, 97–100.
   PubMed Web of Science ®Google Scholar
• Panza, F., Solfrizzi, V., D'Introno, A., Colacicco, A. M., Capurso, C., & Kehoe, P. G. (2003). Shifts in angiotensin I converting enzyme insertion allele frequency across Europe: implications for Alzheimer's disease risk. Journal of Neurology Neurosurgery and Psychiatry, 74, 1157–1161.
   Web of Science ®Google Scholar
• Papapetropoulos, S., Glynos, K., Zhou, Z., Orfanos, S. E., Mitsi, G., & Papapetropoulos. (2008). The insertion/deletion polymorphism of the angiotensin converting enzyme (ACE) in Parkinson's disease. The Open Neurology Journal, 2, 66–70.
   PubMedGoogle Scholar
• Rigat, B., Hubert, C., Alhenc-Gelas, F., Corvol, P., & Soubrier, F. (1990). An insertion/ deletion polymorphism in angiotensin converting enzyme gene accounting for half the variance of serum enzyme levels. Journal of Clinical Investigation, 86, 1343–1346.
   PubMed Web of Science ®Google Scholar
• Savaskan, E., Hock, C., Olivieri, G., Bruttel, S., Rosenberg C, Hulette C, (2001). Cortical alterations of angiotensin converting enzyme, angiotensin II and AT1 receptor in Alzheimer's dementia. Neurobiology of Aging, 22, 541–546. [PubMed: 11445253]
   PubMed Web of Science ®Google Scholar
• Selkoe, D. J. (1991). Amyloid protein and Alzheimer's disease. Scientific American, 265(5), 68–71, 74–76, 78. Review.
   PubMed Web of Science ®Google Scholar
• Selkoe, D. J. (2001). The molecular pathology of Alzheimer's disease. Neuron, 6, 487–498.
   Google Scholar
• Skidgel, R. A., & Erdos, E. G. (1987). The broad substrate specificity of human angiotensin I converting enzyme. Clinical and Experimental Hypertension, 9, 243–259. [PubMed: 2440624].
   Web of Science ®Google Scholar
• Taylor, A., Ezquerra, M., Bargri, G., Yip, A., Goumidi, L., & Cottel, D. (2001). Alzheimer's disease not associated with polymorphism in the angiotensinogen and rennin genes. American Journal of Medical Genetics, 105, 761–764.
   PubMed Web of Science ®Google Scholar
• Van Duijn, C. M., Hendriks, L., Cruts, M., Hardy, J. A., Hofman, A., & Van Broeckhoven, C. (1991). Amyloid precursor protein gene mutation in early-onset Alzheimer's disease. Lancet, 337, 978.
   PubMed Web of Science ®Google Scholar
• Zhang, J. W., Li, X. Q., Zhang, Z. X., Chen, D., Zhao, H. L., Wu, Y. N. (2005). Association between angiotensin converting enzyme gene polymorphism and Alzheimer's disease in Chinese population. Dementia and Geriatric Cognitive Disorders, 20(1), 52–56.
   PubMed Web of Science ®Google Scholar